Post-Market Clinical Investigation of NanoFUSE® Bioactive Matrix

PHASE4UnknownINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

February 28, 2019

Primary Completion Date

March 31, 2021

Study Completion Date

March 31, 2021

Conditions
Bone; Degeneration
Interventions
DEVICE

NanoFUSE® Bioactive Matrix

NanoFUSE® is placed into bony voids or gaps of the skeletal system that are not intrinsic to the stability of the bony structure.

Sponsors
All Listed Sponsors
lead

NanoFUSE Biologics, LLC

INDUSTRY

NCT03762811 - Post-Market Clinical Investigation of NanoFUSE® Bioactive Matrix | Biotech Hunter | Biotech Hunter